Cell pics by GE contest winners to light up Times Square

Updated on 28 February 2013

GE Healthcare’s 6-year-old annual competition showcases the beauty of cells and the inspiring research conducted by cellular biologists around the world. The cellular images of prize-winners will be displayed in Times Square on April 19-21

ge-healthcare-2012-cell-imaging-competition-winners-ms-jane-stout-ms-anushree-balachandran-and-mr-markus-posch

GE Healthcare 2012 Cell Imaging Competition winners - Ms Jane Stout, Ms Anushree Balachandran and Mr Markus Posch

Singapore: GE Healthcare Life Sciences has chosen Ms Jane Stout (from the US), Ms Anushree Balachandran (from Australia) and Mr Markus Posch (from the UK) as winners of the GE Healthcare 2012 Cell Imaging Competition. The winners were chosen based on 15,000 votes cast by public. The cellular images of the prize-winners will be displayed in Times Square, New York, US, on NBC Universal's HD screen at a special event on April 19-21, 2013.

Ms Stout, who is from the School of Medicine, Indiana University, US, won the first place in Microscopy category for her image (focusing on Cancer) on 'metaphase epithelial cell stained for microtubules (red), kinetochores (green) and DNA (blue)'.

Ms Balachandran, who is from Genea, Sydney, Australia, won the first place in High-Content Analysis category for her image (focusing on Huntingdon's disease) on 'Huntington's stem cell derived oligodendrocyte precursors stained for phalloidin (green), vinculin (red) and DNA (blue)'.

Mr Posch, who is from the Center for Gene Regulation and Expression, University of Dundee, UK, was the Regional Winner in Microscopy category for his image (focusing on Cancer) on 'prometaphase human cervical carcinoma (HeLa) cell with GFP-histone labeled chromosomes (blue) stained for tubulin (yellow)'.

Now in its sixth year, GE Healthcare's annual competition showcases the beauty of cells and the inspiring research conducted by cellular biologists around the world. In 2012, for the first time, there were two categories for submission, including high-content analysis and microscopy.

Previous 1

Leave a Reply

Notify me of follow-up comments via e-mail address

Post Comment

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X